These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22855165)

  • 1. miRNAs as biomarkers in prostate cancer.
    Casanova-Salas I; Rubio-Briones J; Fernández-Serra A; López-Guerrero JA
    Clin Transl Oncol; 2012 Nov; 14(11):803-11. PubMed ID: 22855165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs as novel biomarkers in the management of prostate cancer.
    Filella X; Foj L
    Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
    Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
    J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
    Barceló M; Castells M; Bassas L; Vigués F; Larriba S
    Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of biomarkers for the diagnosis and assessment of treatment efficacy of prostate cancer.
    Liu J; Li Y; Yang D; Yang C; Mao L
    Discov Med; 2019 Jun; 27(150):235-243. PubMed ID: 31421692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of genetic markers in the management of prostate cancer.
    Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
    Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in prostate cancer: Functional role as biomarkers.
    Kanwal R; Plaga AR; Liu X; Shukla GC; Gupta S
    Cancer Lett; 2017 Oct; 407():9-20. PubMed ID: 28823964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancer.
    Leyten GH; Hessels D; Jannink SA; Smit FP; de Jong H; Cornel EB; de Reijke TM; Vergunst H; Kil P; Knipscheer BC; van Oort IM; Mulders PF; Hulsbergen-van de Kaa CA; Schalken JA
    Eur Urol; 2014 Mar; 65(3):534-42. PubMed ID: 23201468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?
    Zhao Z; Stephan C; Weickmann S; Jung M; Kristiansen G; Jung K
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28934131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers.
    Filella X; Foj L
    Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of cell-free and exosomal microRNAs as biomarkers in liquid biopsy in patients with prostate cancer.
    de Nóbrega M; Dos Reis MB; Pereira ÉR; de Souza MF; de Syllos Cólus IM
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2893-2910. PubMed ID: 35922694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
    Ghafouri-Fard S; Shoorei H; Taheri M
    Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational Research for Identifying Potential Early-stage Prostate Cancer Biomarkers.
    Nakamura N; Rogers P; Eggerson R; Post SR; Davis R
    Cancer Genomics Proteomics; 2023; 20(1):1-8. PubMed ID: 36581341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
    Jin W; Fei X; Wang X; Chen F; Song Y
    J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
    Bertoli G; Cava C; Castiglioni I
    Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive biomarkers in prostate cancer.
    Kontos CK; Adamopoulos PG; Scorilas A
    Expert Rev Mol Diagn; 2015; 15(12):1567-76. PubMed ID: 26548550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.